Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.
Raineri, S.M., Cortegiani, A., Vitale, F., Iozzo, P., Giarratano, A. (2017). Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?. JOURNAL OF INTENSIVE CARE, 5(1), 58 [10.1186/s40560-017-0252-x].
Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?
Raineri, Santi Maurizio;Cortegiani, Andrea
;Vitale, Filippo;Iozzo, Pasquale;Giarratano, Antonino
2017-01-01
Abstract
Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.File | Dimensione | Formato | |
---|---|---|---|
s40560-017-0252-x.pdf
accesso aperto
Dimensione
275.27 kB
Formato
Adobe PDF
|
275.27 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.